BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15286668)

  • 1. An unusual appearance of limbal conjunctival follicles in a patient on brimonidine and dorzolamide.
    Gupta R; Vernon SA
    Eye (Lond); 2005 Mar; 19(3):356-8. PubMed ID: 15286668
    [No Abstract]   [Full Text] [Related]  

  • 2. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
    Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual side effect of Dorzolamide.
    Zambarakji HJ; Spencer AF; Vernon SA
    Eye (Lond); 1997; 11 ( Pt 3)():418-9. PubMed ID: 9373489
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drugs in glaucoma therapy].
    Gramer E
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
    [No Abstract]   [Full Text] [Related]  

  • 9. Accelerated idioventricular rhythm associated to ophthalmic timolol/dorzolamide solution.
    Attanasio A; Baglio S; Quatrana M; Bartorelli L
    Int J Cardiol; 2004 Jun; 95(2-3):343-5. PubMed ID: 15193844
    [No Abstract]   [Full Text] [Related]  

  • 10. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Osborne SA; Montgomery DM; Morris D; McKay IC
    Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal detachment in association with topical dorzolamide: is hypotony always the cause?
    Doherty MD; Wride NK; Birch MK; Figueiredo FC
    Clin Exp Ophthalmol; 2009 Sep; 37(7):750-2. PubMed ID: 19788679
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
    Cates CA; Jeffrey MN
    Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
    [No Abstract]   [Full Text] [Related]  

  • 15. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B; Stewart JA; Nelson LA; Stewart WC
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F; Ermis SS; Inan UU
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced ectropion: what is best practice?
    Hegde V; Robinson R; Dean F; Mulvihill HA; Ahluwalia H
    Ophthalmology; 2007 Feb; 114(2):362-6. PubMed ID: 17270684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact dermatitis caused by allergy to dorzolamide.
    Linares Mata T; Pardo Sánchez J; de la Cuadra Oyanguren J
    Contact Dermatitis; 2005 Feb; 52(2):111-2. PubMed ID: 15725294
    [No Abstract]   [Full Text] [Related]  

  • 19. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
    Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
    Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.
    Mullins RJ; Lones R; Dutta B
    Australas J Dermatol; 2004 May; 45(2):151-2. PubMed ID: 15068470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.